Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02349113Phase 1Completed
Phase 1, open-label, single-arm trial of estradiol topical in osteoporosis, sponsored by Mayo Clinic. Primary endpoint: Gene expression (RNAseq analysis) at 3 weeks. Started Feb 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02349113.